Galapagos initiates Phase 3 program with filgotinib in patie

Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritis

finanzen.ch - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanzen.ch Daily Mail and Mail on Sunday newspapers.

Related Keywords

United Kingdom , Mechelen , Region Flamande , Belgium , Ruhr , Nordrhein Westfalen , Germany , Northern Ireland , Craigavon , Bochum , Japan , Great Britain , Japanese , Elisa Chenailler , Van Gijsel , Sandra Cauwenberghs , Daniele Dambrosio , Marieke Vermeersch , Xenofon Baraliakos , Percentage Of Participants Achieving Spondyloarthritis International Society , European Union , Japanese Ministry Of Health , European Medicines Agency , Gilead Sciences Inc , Exchange Commission , University Bochum , Axspa Topline , Ankylosing Spondylitis Disease Activity Score , Internal Medicine , Ruhr University Bochum , Coordinating Investigator , Danieled Ambrosio , Therapeutic Area Head , European Summary , Product Characteristics , Great Britain Summary , Northern Ireland Summary , Japanese Ministry , Gilead Sciences , Annual Report , Ankylosing Spondylitis , Der Heijde ,